Cattle Vaccine Market Size, Share, Growth, and Industry Analysis, By Type (Live Attenuated Vaccine, Inactivated Vaccine and Others), By Sales Channel (Government Bidding and Market Sales), Regional Insights and Forecast to 2032

Updated On: 22 April 2024

CATTLE VACCINE MARKET REPORT OVERVIEW

• 

• Request a Free Sample to learn more about this report

global cattle vaccine market size was USD 1481.9 million in 2020 and market is projected to touch USD 3039.12 million by 2032 at CAGR 6.2% during the forecast period.

Cattle vaccines play a crucial role in safeguarding cattle from potential threats posed by viruses, bacteria, and parasites, particularly those responsible for neonatal diarrhoea or calf scours. By stimulating the immune system of cows, vaccination provides a significant advantage in the fight against various illnesses. This proactive approach not only enhances the overall health of cattle but also contributes to the quality of animal-derived food products. The protection afforded by vaccines extends to preventing a spectrum of diseases in cattle, including respiratory ailments, clostridial infections, pink eye, bovine ephemeral fever, and others that can adversely impact productivity, and fertility, or even lead to fatalities.

The administration of cattle vaccines varies, with options ranging from oral doses to injections or intranasal sprays. The choice of method depends on the specific type of vaccine and the targeted disease. Whether bolstering immunity against respiratory challenges or guarding against clostridial threats, the strategic use of vaccines promotes the overall well-being of cattle and plays a pivotal role in sustaining the health and productivity of livestock, ultimately benefiting the quality of animal-derived products for human consumption.

COVID-19 Impact: Reduced clinic visits cause market decline revealing vulnerability amid pandemic pressures

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The market experienced a decline in growth primarily due to a significant drop in cattle visits to hospitals and clinics for vaccination and treatment. Despite concerted efforts, the market could not evade negative growth, as the impact of reduced cattle visits proved insurmountable. The market's vulnerability became apparent as mitigating circumstances fell short, failing to offset the consequences of decreased veterinary service utilization. These inadequacies acted as destabilizing factors, resulting in an overall contraction in market size. Challenges in adapting to adverse conditions further exacerbated the market's downturn. This negative trend underscores the industry's susceptibility to external pressures, raising concerns about its ability to sustain positive growth in the face of obstacles and uncertainties in the veterinary landscape.

LATEST TRENDS

"Advancements in vaccine technologies are driving the expansion of the market"

Progress in vaccine technologies, characterized by the continual refinement and creation of vaccines that are both more efficacious and safer, significantly propels market expansion. Ongoing advancements in vaccine development play a pivotal role in enhancing the overall landscape of the industry. The evolution of these technologies underscores a commitment to improving the effectiveness and safety profiles of vaccines in preventing diseases among cattle. This innovation-driven approach not only addresses current challenges but also positions the market for sustained growth by meeting the evolving needs of the agricultural sector. The continual pursuit of more sophisticated and reliable vaccine solutions reflects the industry's dedication to elevating standards in livestock health and disease prevention.

CATTLE VACCINE MARKET SEGMENTATION

• 

• Request a Free Sample to learn more about this report

• By Type

Based on type the global market can be categorized into Live Attenuated Vaccine, Inactivated Vaccine and Others.

Live Attenuated Vaccine: Live attenuated vaccines for cattle employ weakened forms of pathogens, stimulating a robust immune response without causing disease. This type offers prolonged protection and is often favoured for its efficacy but requires careful handling to maintain viability.

Inactivated Vaccine: Inactivated cattle vaccines consist of killed pathogens, ensuring safety while inducing an immune response. Although they may require booster doses for sustained immunity, these vaccines are advantageous for avoiding the risk of reversion to virulence associated with live vaccines.

Others: The 'Others' category in cattle vaccines includes innovative approaches such as subunit or DNA vaccines, showcasing ongoing research to advance disease prevention. This category reflects a commitment to exploring cutting-edge technologies for enhanced efficacy and safety in safeguarding cattle health.

• By Sales Channel

Based on sales channel the global market can be categorized into Government Bidding and Market Sales.

Government Bidding: In the cattle vaccine market, Government Bidding involves procurement through official tenders. This channel ensures regulatory compliance and often serves as a strategic means for large-scale vaccination programs to control and prevent diseases in livestock.

Market Sales: Market Sales in the cattle vaccine sector involve transactions through commercial channels, such as veterinary clinics, retailers, and distributors. This direct sales approach allows flexibility and accessibility for farmers and livestock owners seeking vaccines for their cattle health management.

DRIVING FACTORS

"Surging demand for cattle proteins propels growth emphasizing the pivotal role of the market"

The growing demand for cattle proteins, driven by increasing population, income levels, and dietary preferences, directly impacts the global cattle vaccine market growth. As the demand for beef and dairy products rises, there is a heightened emphasis on ensuring the health and productivity of cattle herds. Cattle vaccines play a pivotal role in disease prevention, enhancing the overall well-being of livestock, and consequently, the quality of animal-derived products. The need for efficient and sustainable livestock farming practices to meet the escalating demand underscores the significance of robust vaccination programs. In this context, the market is poised to witness continued growth as it becomes an integral component of strategies supporting the thriving cattle protein industry.

"Rising prevalence of zoonotic diseases is expanding the market"

The heightened prevalence of zoonotic diseases, which can be transmitted from animals to humans, accentuates the critical role of the market. As zoonoses pose significant public health risks, there is a growing imperative to safeguard cattle health to prevent potential disease transmission. Cattle vaccines become integral tools in mitigating zoonotic threats, offering a proactive approach to disease control. By immunizing cattle against pathogens that have zoonotic potential, the market contributes to reducing the risk of disease outbreaks and enhancing food safety. The increased focus on zoonotic diseases not only underscores the interconnectedness of cattles and human health but also reinforces the pivotal position of the market in addressing emerging health challenges.

RESTRAINING FACTORS

"Financial impact emphasizes the role of regulatory approval in shaping the market"

Securing marketing approval for new vaccines from regulatory agencies is a resource-intensive and time-consuming process within the market. The financial stability of companies engaged in vaccine development is intricately tied to their proficiency in obtaining and retaining these regulatory approvals. The stringent requirements imposed by regulatory bodies demand extensive testing, documentation, and adherence to safety and efficacy standards. These procedures contribute significantly to the overall cost and timeline of vaccine development. The financial impact on companies underscores the critical nature of regulatory approvals, acting as a decisive factor influencing market dynamics. The ability to navigate and comply with regulatory processes not only shapes the success of individual vaccines but also plays a pivotal role in determining the competitiveness and sustainability of companies in the market.

CATTLE VACCINE MARKET REGIONAL INSIGHTS

• 

• Request a Free Sample to learn more about this report

"North America is driving the market due to its advanced infrastructure"

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America commands market dominance, propelled by its sophisticated research and development infrastructure, a factor anticipated to continually fuel the global cattle vaccine market share. The advanced technological landscape within North America creates an environment conducive to innovation and scientific advancements, particularly in the field of cattle vaccines. This robust infrastructure not only facilitates effective research but also enhances the development and deployment of cutting-edge veterinary solutions. The region's commitment to technological progress positions it as a key driver in the continual growth of the market. The prevailing advanced infrastructure signifies North America's pivotal role in shaping the industry's landscape and fostering sustained advancements in the field of cattle health.

KEY INDUSTRY PLAYERS

"Key industry players position themselves for market leadership and shaping the dynamic"

Prominent key industry players in the market prioritize research and development, employing advanced technologies to innovate effective solutions. Their commitment to cutting-edge approaches ensures the creation of safe and potent vaccines, targeting prevalent cattle diseases. Collaboration with regulatory bodies underscores dedication to compliance, and navigating the complexities of obtaining necessary approvals. A presence and extensive distribution networks characterize these industry leaders, facilitating widespread accessibility to their products. Collectively, these factors contribute to the competitive edge and market influence of these key players in the dynamic cattle vaccines market.

List of Market Players Profiled

• Merck Animal Health (U.S.)
• Zoetis (U.S.)
• Boehringer Ingelheim (Germany)
• Ceva (France)
• Jinyu Bio-Technology (China)
• CAHIC (China)
• TECON (China)

INDUSTRIAL DEVELOPMENT

December 2023: Governor Ahmadu Umaru Fintiri of Adamawa State launched the 2023 mass vaccination against transboundary animal diseases at the Gerei International Cattle Market. Represented by Chief of Staff Edgar Amos Sunday, Fintiri emphasized the crucial role of animal vaccination in public health and the livestock sector's GDP contribution. Commissioner Tijjani Maksha highlighted the campaign against contagious bovine pleuropneumonia and peste des petits ruminants. Stakeholders were urged to ensure vaccination success, and local officials commended Fintiri's support for public health and economic development in Girei.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.